20 Dec Year in review: Who were the main DCT players in 2022?

Clinical Trials Arena reviews the companies and countries that mentioned decentralisation most often in their clinical trial protocols.

By Urtė Fultinavičiūtė and Irena Maragkou, Clinical Trials Arena

s we count down to the end of 2022, we look at the sponsors, CROs, and sites that were at the top of the decentralised clinical trial (DCT) race. We also explore the countries where DCTs were frequently conducted.

Clinical Trials Arena has established an exclusive taxonomic approach that involves reviewing thousands of drug trial public records from 2022 that mentioned decentralisation terminology in the study protocols, as curated in the Clinical Trials Database by GlobalData, the parent company of Clinical Trials Arena. Decentralisation terminology includes DCT elements such as telemedicine, remote monitoring, digital data collection, and more. Read more …